Literature DB >> 19470662

Cyst infections in patients with autosomal dominant polycystic kidney disease.

Marion Sallée1, Cédric Rafat, Jean-Ralph Zahar, Benoît Paulmier, Jean-Pierre Grünfeld, Bertrand Knebelmann, Fadi Fakhouri.   

Abstract

BACKGROUND AND OBJECTIVES: Cyst infection is a complex diagnostic and therapeutic issue in patients with autosomal dominant polycystic kidney disease (ADPKD); however, published data regarding the diagnosis and the management of cyst infections in patients with ADPKD are sparse. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective study was conducted in a referral center for patients with ADPKD in Paris, France. We identified using a computerized database all patients who had ADPKD and were admitted in the nephrology department of Hôpital Necker between January 1998 and August 2008 with likely or definite renal and/or hepatic cyst infection. Medical files of all included patients were reviewed.
RESULTS: Among 389 identified patients with ADPKD, 33 (8.4%) had 41 episodes of cyst infection, including eight definite and 33 likely cases. The incidence of cyst infections in patients with ADPKD was 0.01 episode per patient per year. Microbiological documentation was available for 31 episodes (75%), Escherichia coli accounting for 74% of all retrieved bacterial strains. Positron emission tomography scan proved superior to ultrasound, Computed tomography scan, and magnetic resonance imaging for the detection of infected cysts. Clinical efficacy of initial antibiotic treatment was noted in 71% of episodes. Antibiotic treatment modification was more frequently required for patients who were receiving initial monotherapy compared with those who were receiving bitherapy. Large (diameter >5 cm) infected cysts frequently required drainage.
CONCLUSIONS: Positron emission tomography scan will probably make the diagnosis of cyst infections easier and more accurate. Antibiotic association, including a fluoroquinolone, and the drainage of large infected cysts remain the main treatment for cyst infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470662      PMCID: PMC2709515          DOI: 10.2215/CJN.01870309

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  Gas-forming infection from Clostridium perfringens in a renal cyst of a patient with autosomal dominant polycystic kidney disease.

Authors:  P Sean Van Zijl; Toby C Chai
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

2.  Liver changes and complications in adult polycystic kidney disease.

Authors:  J P Grünfeld; G Albouze; P Jungers; P Landais; A Dana; D Droz; A Moynot; B Lafforgue; E Boursztyn; D Franco
Journal:  Adv Nephrol Necker Hosp       Date:  1985

Review 3.  Cystic kidneys: an enigma evolves.

Authors:  K D Gardner; A P Evan
Journal:  Am J Kidney Dis       Date:  1984-05       Impact factor: 8.860

Review 4.  Renal infections in autosomal dominant polycystic kidney disease.

Authors:  A H Sklar; R J Caruana; J E Lammers; G D Strauser
Journal:  Am J Kidney Dis       Date:  1987-08       Impact factor: 8.860

5.  Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.

Authors:  Chantal P Bleeker-Rovers; Ruud G L de Sévaux; Henk W van Hamersvelt; Frans H M Corstens; Wim J G Oyen
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

6.  Candida krusei renal cyst infection and measurement of amphotericin B levels in cystic fluid in a patient receiving AmBisome.

Authors:  M J Hepburn; G J Pennick; D A Sutton; G E Crawford; J H Jorgensen
Journal:  Med Mycol       Date:  2003-04       Impact factor: 4.076

7.  Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease.

Authors:  S J Schwab; M E Weaver
Journal:  Am J Kidney Dis       Date:  1986-05       Impact factor: 8.860

8.  PH-dependent accumulation of clindamycin in a polycystic kidney.

Authors:  S Schwab; D Hinthorn; D Diederich; F Cuppage; J Grantham
Journal:  Am J Kidney Dis       Date:  1983-07       Impact factor: 8.860

9.  Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys.

Authors:  L W Elzinga; T A Golper; A L Rashad; M E Carr; W M Bennett
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

10.  Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease.

Authors:  W M Bennett; L Elzinga; J P Pulliam; A L Rashad; J M Barry
Journal:  Am J Kidney Dis       Date:  1985-12       Impact factor: 8.860

View more
  56 in total

1.  Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Authors:  Giorgina B Piccoli; Vincenzo Arena; Valentina Consiglio; Maria Chiara Deagostini; Ettore Pelosi; Anastasios Douroukas; Daniele Penna; Giancarlo Cortese
Journal:  BMC Nephrol       Date:  2011-09-29       Impact factor: 2.388

2.  A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.

Authors:  Taro Akihisa; Ayami Ino; Hiroto Egawa; Yoshihito Kotera; Shunichi Ariizumi; Akiko Oomori; Shingo Yamashita; Yusuke Yamamoto; Ken Tsuchiya; Masakazu Yamamoto; Kosaku Nitta; Toshio Mochizuki
Journal:  CEN Case Rep       Date:  2018-06-28

3.  Bacteremic kidney cyst infection caused by Helicobacter cinaedi.

Authors:  Kenta Ito; Takumi Yamamoto; Haruomi Nishio; Asako Sawaya; Masaaki Murakami; Akiko Kitagawa; Yoko Matsuo; Ken Matsuo; Satoshi Tanaka; Noriko Mori
Journal:  CEN Case Rep       Date:  2015-12-10

Review 4.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

5.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

6.  Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics.

Authors:  T Suwabe; H Araoka; Y Ubara; K Kikuchi; R Hazue; K Mise; S Hamanoue; T Ueno; K Sumida; N Hayami; J Hoshino; A Imafuku; M Kawada; R Hiramatsu; E Hasegawa; N Sawa; K Takaichi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-08       Impact factor: 3.267

7.  Diagnostic utility of 18FDG-PET/CT for ADPKD cyst infection.

Authors:  Yoshinosuke Shimamura; Hideki Takizawa
Journal:  Clin Exp Nephrol       Date:  2017-09-14       Impact factor: 2.801

8.  The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts?

Authors:  Yoshiki Tsuchiya; Yoshifumi Ubara; Tatsuya Suwabe; Junichi Hoshino; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Yuji Marui; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2010-12-04       Impact factor: 2.801

9.  Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement.

Authors:  Yasuto Yoneshima; Isamu Okamoto; Masako Arimura-Omori; Shinichi Kimura; Noriko Hidaka-Fujimoto; Eiji Iwama; Taishi Harada; Koichi Takayama; Yoichi Nakanishi
Journal:  Invest New Drugs       Date:  2014-11-30       Impact factor: 3.850

Review 10.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.